Two Investigational Treatments for ALS Show Glimmer of Hope

(MedPage Today) -- The first four treatments in a platform trial for amyotrophic lateral sclerosis (ALS) failed to reach key endpoints in phase II studies, but two treatments -- pridopidine and CNM-Au8 -- showed glimmers of hope.
All treatments...